|
Published by: Global Markets Direct
Published: Apr. 23, 2008 - 278 Pages
Table of Contents
- 1 Table Of Contents
- 1.1 List Of Tables
- 1.2 List Of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Definitions
- 2.2.1 Ophthalmic Devices
- 3 Healthcare Sector Review
- 3.1 Healthcare Expenditure
- 3.2 Healthcare Infrastructure
- 3.2.1 Healthcare Personnel Data
- 3.2.2 Healthcare Facilities Data
- 4 Opthalmic Devices in United states
- 4.1 Ophthalmic Devices Overall Revenues (2000-2012)
- 4.2 Opthalmic Devices Overall Volume (2000-2012)
- 4.3 Opthalmic Devices Overall Company Shares (2005-2006)
- 5 Vision Care in United States
- 5.1 Vision Care Overall Revenues (2000-2012)
- 5.1.1 Spectacles Overall Revenues (2000-2012)
- 5.1.2 Soft Contact Lenses Overall Revenues (2000-2012)
- 5.1.3 Lens Care Overall Revenues (2000-2012)
- 5.1.4 Opthalmoscope Overall Revenues (2000-2012)
- 5.1.5 Rigid Gas Permeable Contact Lenses Overall Revenues (2000-2012)
- 5.2 Vision Care Overall Volume (2000-2012)
- 5.2.1 Spectacles Overall Volume (2000-2012)
- 5.2.2 Soft Contact Lenses Overall Volume (2000-2012)
- 5.2.3 Lens Care Overall Volume (2000-2012)
- 5.2.4 Rigid Gas Permeable Contact Lenses Overall Volume (2000-2012)
- 5.2.5 Opthalmoscope Overall Volume (2000-2012)
- 5.3 Vision Care Average Price
- 5.3.1 Lens Care Average Price (2000-2012)
- 5.3.2 Opthalmoscope Average Price (2000-2012)
- 5.3.3 Rigid Gas Permeable Contact Lenses Average Price (2000-2012)
- 5.3.4 Soft Contact Lenses Average Price (2000-2012)
- 5.3.5 Spectacles Average Price (2000-2012)
- 5.4 Vision Care Distribution Share (2005-2006)
- 5.5 Vision Care Company Share (2005-2006)
- 6 Cataract Surgery in United States
- 6.1 Cataract Surgery Overall Revenues (2000-2012)
- 6.1.1 Phacoemulsification Equipment and Accessories Overall Revenues (2000-2012)
- 6.1.2 Intra Ocular Lens (IOL) Overall Revenues (2000-2012)
- 6.2 Cataract Surgery Overall Volume (2000-2012)
- 6.2.1 Intra Ocular Lens (IOL) Overall Volume (2000-2012)
- 6.2.2 Phacoemulsification Equipment and Accessories Overall Volume (2000-2012)
- 6.3 Cataract Surgery Average Price (2000-2012)
- 6.3.1 Intra Ocular Lens (IOL) Average Price (2000-2012)
- 6.3.2 Phacoemulsification Equipment and Accessories Averaga Price (2000-2012)
- 6.4 Cataract Surgery Distribution Share (2005-2006)
- 6.5 Cataract Surgery Company Share (2005-2006)
- 7 Refractive Surgery in United States
- 7.1 Refractive Surgery Overall Revenues (2000-2012)
- 7.1.1 Refractive Surgery Overall Revenues (2000-2012)
- 7.2 Refractive Surgery Overall Volume (2000-2012)
- 7.2.1 Refractive Surgery Overall Volume (2000-2012)
- 7.3 Refractive Surgery Average Price (2000-2012)
- 7.3.1 Refractive Surgery Average Price (2000-2012)
- 7.4 Refractive Surgery Distribution Share (2005-2006)
- 7.5 Refractive Surgery Company Share (2005-2006)
- 8 Johnson & Johnson Vision Care, Inc. Company Profile
- 8.1 Company Overview
- 8.2 Business Overview
- 8.2.1 Major Products and Services
- 8.2.2 History
- 8.3 Locations And Subsidiaries
- 8.4 Financial Deals Landscape
- 8.4.1 Essilor International Acquires The Spectacle Lens Group From Johnson & Johnson Vision Care
- 8.5 Recent Developments
- 8.5.1 Jan 07, 2008: Court of Appeals Upholds Verdicts in Favor of Cordis Corporation On Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
- 9 Advanced Medical Optics, Inc. Company Profile
- 9.1 Company Overview
- 9.2 Business Overview
- 9.2.1 Cataract/Implant
- 9.2.2 Eye Care
- 9.2.3 Laser Vision Correction
- 9.2.4 Major Products and Services
- 9.2.5 History
- 9.3
- 9.4 Value Chain Analysis
- 9.4.1 Manufacturing
- 9.4.2 Product Development
- 9.4.3 Sales and Marketing
- 9.5 SWOT Analysis
- 9.5.1 Advanced Medical Optics, Inc. Strengths
- 9.5.2 Advanced Medical Optics, Inc. Weaknesses
- 9.5.3 Advanced Medical Optics, Inc. Opportunities
- 9.5.4 Advanced Medical Optics, Inc. Threats
- 9.6 Financial and Operational Review
- 9.6.1 Financial Statements
- 9.6.2 Financial Ratios
- 9.6.3 Share Holding Structure
- 9.7 Locations And Subsidiaries
- 9.8 Financial Deals Landscape
- 9.8.1 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec
- 9.8.2 Advanced Medical Optics Acquires Intralase
- 9.8.3 Advanced Medical Optics Completes Private Placement Of $250 Million
- 9.8.4 Advanced Medical Optics Acquires Wavefront Sciences
- 9.8.5 Optobionics Secures $5 Million In Series D-1 Financing
- 9.8.6 Advanced Medical Optics Completes Private Placement Of $500 Million
- 9.8.7 Advanced Medical Optics Completes Private Placement Of $150 Million
- 9.8.8 Advanced Medical Optics Acquires VISX
- 9.8.9 Advanced Medical Optics Acquires Surgical Ophthalmology Business From Pfizer
- 9.8.10 Advanced Medical Optics Completes Private Placement Of $350 Million
- 9.8.11 Advanced Medical Optics Signs An Agreement With Quest Vision Technologies
- 9.8.12 Advanced Medical Optics to acquire Bausch & Lomb
- 9.9 Recent Developments
- 9.9.1 Feb 14, 2008: Advanced Medical Optics Reports Fourth-Quarter and Full-Year 2007 Results
- 9.9.2 Feb 14, 2008: Advanced Medical Declares Q4 2007 Results
- 9.9.3 Jan 21, 2008: Advanced Medical Optics Announces Release Date for Fourth Quarter and Full-Year 2007 Operating Results
- 9.9.4 Dec 05, 2007: AMO Elects Board Members
- 9.9.5 Nov 19, 2007: AMO Appoints New President
- 9.9.6 Oct 25, 2007: AMO Declares Q3 2007 Results
- 9.9.7 Oct 09, 2007: AMO Appoints CFO
- 9.9.8 Aug 02, 2007: AMO Declares Q2 2007 Results
- 9.9.9 Jul 23, 2007: AMO Set To Re-Enter Multipurpose Solution Market
- 9.9.10 Jun 26, 2007: AMO Revises Financial Guidance 2007 And 2008
- 9.9.11 May 22, 2007: AMO Adds New Board Member
- 9.9.12 Apr 25, 2007: AMO Declares Q1 2007 Results
- 9.9.13 Feb 13, 2007: AMO Declares Q4 2006 Results
- 9.9.14 Oct 26, 2006: AMO Declares Q3 2006 Results
- 9.9.15 Sep 25, 2006: AMO Lowers 2006 EPS, Revenue Guidance
- 9.9.16 Aug 01, 2006: AMO Declares Q2 2006 Results
- 9.9.17 Jun 08, 2006: AMO Increases 2006, 2007 EPS Guidance
- 9.9.18 May 25, 2006: AMO Appoints Chairman
- 9.10 Advanced Medical Optics, Inc. Pipeline Products
- 9.10.1 Sensar Hydrophobic Foldable Intraocular Lenses
- 9.10.2 Tecnis Multifocal intraocular lens
- 9.10.3 Presbyopic LASIK multi-focal
- 9.10.4 Quest accommodating intraocular lens
- 10 Bausch & Lomb Incorporated Company Profile
- 10.1 Company Overview
- 10.2 Business Overview
- 10.2.1 Cataract and Vitreoretinal Surgery Product Category
- 10.2.2 Contact Lenses Product Category
- 10.2.3 Lens Care Product Category
- 10.2.4 Pharmaceuticals Category
- 10.2.5 Refractive Surgery Product Category
- 10.2.6 Major Products and Services
- 10.2.7 History
- 10.3 Value Chain Analysis
- 10.3.1 Manufacturing
- 10.3.2 Product Development
- 10.3.3 Sales and Marketing
- 10.4 SWOT Analysis
- 10.4.1 Bausch & Lomb Incorporated Strengths
- 10.4.2 Bausch & Lomb Incorporated Weaknesses
- 10.4.3 Bausch & Lomb Incorporated Opportunities
- 10.4.4 Bausch & Lomb Incorporated Threats
- 10.5 Financial and Operational Review
- 10.5.1 Financial Statements
- 10.5.2 Financial Ratios
- 10.5.3 Share Holding Structure
- 10.6 Locations And Subsidiaries
- 10.7 Financial Deals Landscape
- 10.7.1 Bausch & Lomb Acquires eyeonics
- 10.7.2 Warburg Pincus Acquires Bausch & Lomb
- 10.7.3 Bausch & Lomb Completes Private Placement Of $650 Million
- 10.7.4 Bausch & Lomb Acquires Soothe Emollient (Lubricant) Eye Drops From Alimera Sciences
- 10.7.5 Bausch & Lomb Acquires Alimera’s OTC Eye Care Product
- 10.7.6 Bausch & Lomb Enters Into A Licensing Agreement With Schering AG
- 10.7.7 Bayer HealthCare Signs An Agreement With Bausch & Lomb
- 10.7.8 Bausch & Lomb Signs An Agreement With Cephalon
- 10.7.9 Bausch & Lomb Signs An Agreement With PTC Therapeutics
- 10.7.10 Bausch & Lomb Acquires Shandong Chia Tai Freda From Sino Biopharmaceutical
- 10.7.11 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement
- 10.7.12 Advanced Medical Optics to acquire Bausch & Lomb
- 10.7.13 Bausch & Lomb Forms A Strategic Alliance With Acufocus
- 10.8 Recent Developments
- 10.8.1 Mar 06, 2008: Bausch & Lomb Appoints CVP, CHRO
- 10.8.2 Feb 05, 2008: J. Raymond Elliott and Richard F. Wallman Join Bausch & Lomb Board of Directors
- 10.8.3 Feb 05, 2008: Bausch & Lomb Appoints New Directors
- 10.8.4 Jan 23, 2008: Bausch & Lomb Appoints New CEO
- 10.8.5 Nov 20, 2007: Bausch & Lomb Appoints Corporate VP And General Counsel
- 10.8.6 Aug 08, 2007: Bausch & Lomb Reports Q2 2007 Results
- 10.8.7 Jul 24, 2007: Bausch & Lomb Declares Quarterly Dividend
- 10.8.8 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon
- 10.8.9 May 10, 2007: Bausch & Lomb Preliminary Q1 2007 Results
- 10.8.10 May 01, 2007: Bausch & Lomb Declares Quarterly Dividend
- 10.8.11 Mar 19, 2007: Bausch & Lomb Appoints New CFO
- 10.8.12 Mar 19, 2007: Bausch & Lomb CFO Retires
- 10.8.13 Mar 06, 2007: Bausch & Lomb Reports Preliminary Q4 And 2006 Results
- 10.8.14 Feb 26, 2007: Bausch & Lomb Declares Quarterly Dividend
- 10.8.15 Dec 22, 2006: Bausch & Lomb’s Listing On NYSE Extended
- 10.8.16 Nov 09, 2006: Bausch & Lomb Reports Preliminary Q3 2006 Results
- 10.8.17 Nov 07, 2006: Bausch & Lomb Declares Quarterly Dividend
- 10.8.18 Nov 06, 2006: Bausch & Lomb Receives FDA Warning Letter Related To Inspection At Greenville
- 10.8.19 Jul 25, 2006: Bausch & Lomb Declares Quarterly Dividend
- 10.8.20 May 02, 2006: Bausch & Lomb Declares Quarterly Dividend
- 10.8.21 Apr 19, 2006: Bausch & Lomb Names New President For Its Asia Region
- 10.9 Bausch & Lomb Incorporated Pipeline Products
- 10.9.1 Safarazi Elliptical Accommodating IOL
- 10.9.2 Akreos AO Micro-Incision sub-2-mm lens
- 11 Carl Zeiss Meditec AG Company Profile
- 11.1 Company Overview
- 11.2 Business Overview
- 11.2.1 Diagnosis
- 11.2.2 Laser and IOL
- 11.2.3 Service
- 11.2.4 Major Products and Services
- 11.3 Value Chain Analysis
- 11.3.1 Manufacturing
- 11.3.2 Product Development
- 11.3.3 Sales and Marketing
- 11.4 SWOT Analysis
- 11.4.1 Carl Zeiss Meditec AG Strengths
- 11.4.2 Carl Zeiss Meditec AG Weaknesses
- 11.4.3 Carl Zeiss Meditec AG Opportunities
- 11.4.4 Carl Zeiss Meditec AG Threats
- 11.5 Financial and Operational Review
- 11.5.1 Financial Statements
- 11.5.2 Financial Ratios
- 11.6 Locations And Subsidiaries
- 11.7 Financial Deals Landscape
- 11.7.1 Carl Zeiss Acquires Acri.Tec
- 11.7.2 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec
- 11.7.3 Carl Zeiss Meditec Acquires 5% Shareholding In Wavelight
- 11.7.4 Carl Zeiss Meditec Acquires IOLTECH
- 11.7.5 Carl Zeiss Meditec And PULSION Medical Systems Enter Into Licensing Agreement
- 11.8 Recent Developments
- 11.8.1 Mar 27, 2008: Grand Opening: Carl Zeiss opens S$30 million demo facility to boost Singapore's R&D excellence
- 11.8.2 Jan 22, 2008: New Sales Manager: Reorganization of Sales at Carl Zeiss Sports Optics
- 11.8.3 Oct 08, 2007: CZM Appoints New Board Member
- 11.8.4 Aug 23, 2007: CZM Announces Supervisory Board Changes
- 11.8.5 Aug 08, 2007: CZM First Nine Months 2007 Results
- 11.8.6 Mar 01, 2007: CZM Reports Fiscal 2005/06 Results
- 11.8.7 Feb 14, 2007: CZM Reports Q1 2006/07 Results
- 11.8.8 Nov 13, 2006: CZM Lawsuit with IntraLase
- 11.8.9 Oct 13, 2006: CZM Wins Against Complainants In Court
- 11.8.10 Sep 11, 2006: CZM Appoints Executive Board Member
- 11.9 Carl Zeiss Meditec AG Pipeline Products
- 11.9.1 IOL Master
- 11.9.2 VISULAS 690 PLUS
- 11.9.3 Multifocal IOL
- 11.9.4 New laser system
- 11.9.5 VisuCAm platform(New applications)
- 12 CIBA Vision Corporation Company Profile
- 12.1 Company Overview
- 12.2 Business Overview
- 12.2.1 Major Products and Services
- 12.2.2 History
- 12.3 Locations And Subsidiaries
- 12.4 Financial Deals Landscape
- 12.4.1 CIBA Vision And CooperVision Enter Into A Licensing Agreement
- 12.4.2 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement
- 12.4.3 CIBA Vision Sells Its Surgical Business To IOLTECH
- 12.4.4 CIBA Vision Signs An Agreement With Optonol
- 12.5 Recent Developments
- 12.5.1 Nov 21, 2007: CIBA Vision Settles Patent Litigation With CooperVision
- 12.5.2 Feb 21, 2006: CIBA Vision Appoints New CEO
- 12.5.3 Apr 02, 2004: CIBA Vision Appoints New Finance Officer
- 12.5.4 Apr 02, 2004: CIBA Vision Appoints New President
- 12.6 CIBA Vision Corporation Pipeline Products
- 12.6.1 Non-Moulded Soft Contact Lenses
- 13 Regulation System
- 13.1 Medical Equipment Approval Process
- 13.1.1 Pre-market Approval Process
- 13.1.2 Intended use and Indications for use
- 13.1.3 Predicate Device
- 13.1.4 Safe and Effective
- 13.1.5 Other Category Devices
- 13.1.6 Post-Market Approval Process
- 13.1.7 Compliance and Enforcement
- 13.1.8 Registration Fee
- 13.1.9 Approval Time
- 14 Pricing and Reimbursement
- 14.1 Government Policies
- 14.2 Private Insurance
- 14.3 Diagnosis Related Groups (DRG)
- 15 Distribution Structure
- 15.1 Distribution Structure
- 16 APPENDIX
- 16.1 Global Markets Direct Research Methodology
- 16.2 Coverage
- 16.3 Secondary Research
- 16.4 Primary Research
- 16.5 Models
- 16.6 Forecasts
- 16.7 Expert Panels
- 16.8 Contact Us
- 16.9 Disclaimer
AbstractUnited States Ophthalmic Devices Medical Equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating to United States ophthalmic devices medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices medical equipment in United States.
Scope- The report provides sector information broken down into detailed categories and segments in country.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Note: Some content types may not be available in this report
Reasons to buy - Gain a strong understanding of the industry at a global level, with break downs for the country
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
